# FDA Inspection 1312292 - Blood Assurance Inc. Clarksville Donor Center - April 09, 2026

Source: https://www.keypedia.com/records/fda_inspections/blood-assurance-inc-clarksville-donor-center/762b9df5-66fd-4364-8cb7-2c0a14120242
Source feed: FDA_Inspections

> FDA Inspection 1312292 for Blood Assurance Inc. Clarksville Donor Center on April 09, 2026. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1312292
- Company Name: Blood Assurance Inc. Clarksville Donor Center
- Inspection Date: 2026-04-09
- Classification: No Action Indicated (NAI)
- Project Area: Blood and Blood Products
- Product Type: Biologics
- Office Name: Center for Biologics Evaluation and Research

## Related Documents

- [FDA Inspection 1155362 - 2021-10-27](https://www.keypedia.com/records/fda_inspections/blood-assurance-inc-clarksville-donor-center/6f0a41af-34b0-4be8-b5a6-a73c10b7a8c1)
- [FDA Inspection 1155362 - 2021-10-27](https://www.keypedia.com/records/fda_inspections/blood-assurance-inc-clarksville-donor-center/623139f4-bc54-4ed7-ae14-9f66bd3bc964)

Company: https://www.keypedia.com/companies/blood-assurance-inc-clarksville-donor-center/5d7c7fcb-71d0-420f-a347-d97a5b52c1aa

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d